This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

Cloxacillin Sodium for Injection 500mg

Starting date:
July 18, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-34919

Recalled products

  1. Cloxacillin Sodium for Injection 500mg

Reason

High out-of-specification test assay results at the 17-month time point.

Depth of distribution

Wholesalers, pharmacies, and hospitals across Canada.

Affected products

A. Cloxacillin Sodium for Injection 500mg

DIN, NPN, DIN-HIM
DIN 01912429
Dosage form

Powder for solution

Strength
  • 500 mg / vial
Lot or serial number
  • BN2418
Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA